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We nute with intcrcst the study by Miiggc et al. (1). which appcitred in 
the same issue ot’ the Sournal as our own study (7). which examined left 
atria1 appendage function and thrc~nboembolism in patients with atrial 
fibrillation. Although there were many points of agreement between 
the studies. particularly with regard to Ihe relation between luw left 
atrial appendage blood vclucity and the risk of spontaneous echo 
contrast and thromhus furmation, somewhat diRering conclusions wcrc 
reached with regard tu the relaliun between IOW left atrial appcndagc 
blood vclucity and previous emholic cvcnts. Miigge et al. found that h 
(60%) of IO patients wi h nonvalvular atrial fibrillation imd a “low Iluw 
prolilc” (~25 cm/s) left atrial appcndagc Doppler bluud Ilow pttertl 
had tl history of systemic cmhulic events (ischemic stroke or peripheral 
cmbulismj. whereas only I (5%) of 19 patients with a “high Row 
profile” (>25 cm/s) velocity pattern had a bistoq of such events (p < 
0.05). It was concluded from these results that patients with low left 
atrial appendage blood velocity may be at increased risk fur thrumbu- 
embulic complications. However, it is nntablc that the mean left atrial 
appendage blood velocity in the additional group of 12 patients with 
chronic atrial fibrillation and mitral stenosis studied by Miigge et al. 
was considerably lower than that of the patients with nonvalvular atrial 
fibrillation and a low flow profile; yet only two of the former patients 
(17%) had a history of embolic events. Sixteen (53%) of the 30 control 
patients in sinus rhythm with a high left atrial appendage velucrty also 
bad ia history of embulic evenh. 
In contrast, in our recent study (2) in a heterogeneous group of 140 
patients with nonvalvular and valvular atrial fibrillation. no clear 
relation was demonstrated between a history of systemic embulic 
events (ischemic strukc, transient cerebral ischemic attacks or pcriph- 
era1 embolism) and any of the five left atrial appendage blood velocity 
patterns observed. To determine whether differences in patient groups, 
definition of outcome: events or classification of left atrial appendage 
blood velocity patterns contributed to the different results of these 
studies, we have reanalyzed our data according to the methuds 
described by Miigge et a!. From the 140 paiicnts, a subgroup (;f 85 
patients with nunva\vu8ar atria! t?briPlatiran. a[( of whom wc~c in atriai 
fibrillation at the time of study, were identified (chronic atrial fibrilla_ 
h in 54 p:ttients, pasu.Xysmal atria! fibni&tian in 21, first cpisudc 
atria! fibrillation in 9j. No statistically significant dillcrcnccs were 
fOMld ill IhC pKV&tlCe of previous stroke or pefi@er$ e&&m 
b~Rvtx.m those patients With lefi arriai appendage bPooJ V&C@ 
<25 cm/s and those with velocity >25 cm/s (13 [3O%] of 44 VS. 7 [$7%] 
uf 41). IflOreOVer, the mean velocity in the 20 patients with embulic 
events (24 2 I3 cm/s, range 8 to 59) was nut significantly d&rent from 
that in the 65 patients without events (29 + 15 cm/s, range 7 to 69). 
~edlOrSt et al. (3) have also examined left atrial appendage blood 
velocity and embolic events in 54 patiems with nonvalvular atrial 
fibrillation, 23 (43%) of whom had paroxysmal atrial fibrillatioli alld 
were in sinus rhythm at the time of study. 111 that study, statjstjcally 
significant diflcrenccs were found in the mean left atrial appendage 
VClOCiiy btttWlCl1 10 piltik!~IS with ih hiStOly Ui’ ischcmic StrOl;e (25 2 
ItI Cm/s) aad 38 paticrils without stroke (39 2 33 cm/s, p < 0.115). When 
WC ~GUI$UC~ our data tu include 24 paticuts with paroxysmal atrial 
librillatiun studied in sinus rhythm, we found Ulai the mean left atrial 
appcndago v&city in 26 patients with embolic events (32 & 23 cm/s) 
W;PS IlOt significmrly dill’crcnt from that in X3 pit(iCllh wiihouc evcnl:, 
(3s 2 21 an/s). 
The inability to demonstrate a velocity-dependent increase in 
embulic events in a larger patient cohort, using the same methods as 
those used by other investigators, raises the possibility that the results 
reported by Miigge et al. (I) and Vcrborst et al. (3) may reflect chance 
findings in relatively small patient groups. Bt may also reflect the many 
confounding variables in retrospective analyses of this nature, HI is 
ditlicult to control fur treatment effects, fur example. Whereas antico- 
agulant therapy may have prevented strukcs in some patients, othrn 
may have commenced receiving anticoagulant therapy after an embulic 
event. iln addition, although ischemic strokes in patients with atrial 
fibrillation are presumed cardiucmbolic in origin, it is possible that 
carotid or ccrchrov;~sCular a1llCrosclcrosis may b12 lhr primary much- 
nnism responsible in a considerable proportion of cases. Finally, 
although our study and that of Miiggc ct al. arc in agrccmcnt that IOW 
left atrial appendage bluud v&city promotes spontaneous echo 
contrast and thrombus furmaGun, it is possible that intermediate or 
higher blood velocities or variable hemudynamic conditions may favor 
embulization (2). 
The relation between left atrial appendage blood velocity. sponta- 
neous echo contrast and thrumbus ftirmatiun is important because the 
finding of low velocities in patients with atrial fibrillation may influence 
the decision to commence anticoagulant therapy. However, proof of 
the therapeutic eficacy of such treatment slratification would require 
controlled, randomized, prospective evaluation. Given the existing 
data on anticoagulant therapy in patients with atrial fibrillation (4-7), 
jt is unlikely, on ethical grounds, that such studies will he conducted. 
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111 OIN aeGcIc (I), WC compared the left atria! iq~~ntla~c blood 
vclocitics illIMl~ pih!W4 in sinus rhythm, ittriill fihrilletb~~ dus 10 
!kWPC tAMI stcmsis ;Itd lll~ll~hCl~tlli~liC ;liriill lihrillirtiOn. Our con- 
clusions wcrc, that Ihc lcfi atrial apiXnd+ Hood velocity appears to 
bc hctcropnaus in paticms with nonrhcumatic Wial IibrillaGon. imd 
wc identillcd IWO subgroups. one with a “high tlow protilc” and the 
other with a “low tlow protilc.” LkCilllSC the I;lttCr CIOWI~ WSL!fllblCS 
that sc~l in paticms with scvcrc mitral stenosis, wc concluded that a 
IOW How prolilc of left atrial appcndagc blood velocity may hc klpful 
to identify a subgroup of patients with nonrhcumatic atrial fibrillation 
at increased risk for thrombus formation and subsequent cardiogcnic 
embolism. This conclusion WIS supported by the ohscrvation that a 
spontaneous echo contrast phcnomcnon as an (indirect) indicator for 
thromhus formation was more frequently found (W’i ) in patients with 
:I IOW ~IOW profile than in those with a high tlow profile (3’;:): 
furthcrmorc. three thromhi confined to the left iWhl tl~~prndagc wcrc 
noted, ail three of the patients were in the low How group. The 
argument of Fatkin et al. that this risk strategy does not hold true 
because the actual incidence of (clinical evident) embolism did not 
correspond with the left atrial appendage function is based on a 
misleading interpretation of our data. Most patients with rheumatic 
atria1 Ghriliation in our study were treiltcd with ihcoi@nnt apts. 
Thus, wc wcrc not able to demonstrm tht ilherr is ali increased 
incidcncc of thrombus formation and embolism in these patients; 
however, I think that this might be superfluous because it is well 
known. Furthermore, the argument that there was i\ high incidence of 
“cmbolic cvcnts” in pat::ots in sinus rhythm is not correct. %n fact. 
patients ..! sinus rhythm underwent ranscsophageal cchocardiograpby 
for various S’WSWS. The ~lil~~ indication Was indeed ischemic stroke; 
IlOWCVcr, this iCkirlion ftW CChoCilrdbogrilpl?CC t!Xiillli~lillit~l~ dOL’S Wl 
imply at all Ihat cardiogcnic embolism had readily OCCUIW~. Tkse 
il~#lllN!lltS rctlcct UK prillCipid dillicultics itl i~l~~lgy~~~~ tlIC XMCii1ti0n 
IW~\VWII cchoc;lrdiogaphic variables and clinical cvcms hccausc too 
mauy. t~ncl~~l~~~~llcd \?l lihlCS lll2y hL! involved. ilS ~~icl~~i~)~~cd by Fillkill 
Ct ijl. FW this IWlSOIl. WC prcfcrrcd in 11111‘ Stlldy l0 CtMllpXc lX%OCiIT~ 
ditrgraphic variahlcs bc~~cn ditfcrcnt groups of paticms who wcrc 
k!MWfl for rhcir cmbalic risk ratbcr than to CMWliW ~~tl;Ultili~liVC 
ViiriilhkS with Xlltill (8101 WCll d&cd) clinicai cvcllls. 
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